8N9-19466-22252 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-02-03
Dose 1 — Pfizer-BioNTech
2022-02-05
Registered in v-safe
2022-02-05
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · Site: Pain · Nausea, Abdominal pain

Adult check-in
2022-02-06
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-02-07
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-02-10
Survey response — day 7, dose 1, dependent
MedDRA: Nasal congestion — Feeling: Good

Free text: Nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-02-17
Health check-in — day 14, dose 1, dependent
Feeling: Good

Adult check-in
2022-02-24
Survey response — day 21, dose 1, dependent
MedDRA: Cough, Diarrhoea, Gastrointestinal viral infection, Lacrimation increased, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: GI virus and possibly viral conjunctivitis. Vomiting and diarrhea for 5 days. Cough and watery eyes.

MedDRA releases: 2024-11 · check-in free text available
2022-02-24
Report sent to call center — day 21, dose 1, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-28
Call successful
Does not wish to fill out VAERS report
2022-03-05
Health check-in — day 28, dose 1, dependent
Feeling: Good

Adult check-in
2022-03-10
Health check-in — day 35, dose 1, dependent
Feeling: Good

Adult check-in
2022-03-17
Survey response — day 42, dose 1, dependent
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid

MedDRA releases: 2024-11 · check-in free text available
2022-05-05
Survey response — 3 months, dose 1, dependent
MedDRA: Headache — Feeling: Fair

Free text: Headaches

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-02-03	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — day 7, dose 1, dependent

2022-02-10

Systemic reaction (other): Nasal congestion

Release 11 — day 21, dose 1, dependent

2022-02-24

Symptoms: GI virus and possibly viral conjunctivitis. Vomiting and diarrhea for 5 days. Cough and watery eyes.

Release 11 — day 42, dose 1, dependent

2022-03-17

Symptoms: Covid

Release 11 — 3 months, dose 1, dependent

2022-05-05

Symptoms: Headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Gastrointestinal viral infection	·	·	✓
SD	Headache	·	·	✓
SD	Lacrimation increased	·	·	✓
SD	Vomiting	·	·	✓
SRO	Nasal congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release